Allogene Therapeutics, Inc. - Common Stock (NQ:ALLO)
2.400
-0.070
(-2.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2026
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore News
Performance
More NewsRead More
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Via Benzinga
Stock Market Today, Jan. 21: ImmunityBio Rises Again As Short-Sellers Face Losses ↗
January 21, 2026
Via The Motley Fool
Topics
Stocks
From Equity Insider
Via GlobeNewswire
The market is filled with gapping stocks in Friday's session. ↗
January 09, 2026
Via Chartmill
Via The Motley Fool
Allogene Arbitration Victory Pressures Cellectis Shares Tuesday ↗
December 16, 2025
Via Benzinga
Allogene Q2 Cash Tops $300 Million ↗
August 13, 2025
Via The Motley Fool
Allogene Narrows Loss in Fiscal Q2 ↗
August 13, 2025
Via The Motley Fool
Frequently Asked QuestionsIs Allogene Therapeutics, Inc. - Common Stock publicly traded?
Yes, Allogene Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Allogene Therapeutics, Inc. - Common Stock trade on?
Allogene Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Allogene Therapeutics, Inc. - Common Stock?
The ticker symbol for Allogene Therapeutics, Inc. - Common Stock is ALLO on the Nasdaq Stock Market
What is the current price of Allogene Therapeutics, Inc. - Common Stock?
The current price of Allogene Therapeutics, Inc. - Common Stock is 2.400
When was Allogene Therapeutics, Inc. - Common Stock last traded?
The last trade of Allogene Therapeutics, Inc. - Common Stock was at 03/13/26 04:00 PM ET
What is the market capitalization of Allogene Therapeutics, Inc. - Common Stock?
The market capitalization of Allogene Therapeutics, Inc. - Common Stock is 341.24M
How many shares of Allogene Therapeutics, Inc. - Common Stock are outstanding?
Allogene Therapeutics, Inc. - Common Stock has 341M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>